Skip to content
›

Innovative In-House Formula Tongbu Fangchan Granules Adds a New Option for Atrial Fibrillation Care

On March 28, the Hebei Provincial Cardiovascular Specialty Traditional Chinese Medicine (TCM) Advantage Alliance, led by the Cardiovascular Department of Hebei Yiling Hospital, was officially established in Shijiazhuang. During the academic report session of the alliance’s inaugural conference, the cardiovascular expert team from Hebei Yiling Hospital presented a special report on the integrated Chinese-Western medicine comprehensive management model for the full cycle of atrial fibrillation (AF). The innovative in-house formula Tongbu Fangchan Granules, used in the full-course management of AF—including paroxysmal AF, persistent AF, and full-cycle prevention and control after radiofrequency ablation—was a highlight of the academic session. As the leading unit of the alliance, Hebei Yiling Hospital has been deeply engaged in integrated Chinese-Western cardiovascular disease diagnosis and treatment for decades. Tongbu Fangchan Granules is a core innovative achievement developed under the guidance of the collateral-disease theory.

Relying on the systematically constructed TCM collateral theory, the cardiovascular research team at Hebei Yiling Hospital has conducted extensive research on the pathogenesis of AF and integrated Chinese-Western interventions for many years. They innovatively proposed the core pathogenesis theory of AF as “primary deficiency of ancestral qi and collateral deficiency leading to insufficient nourishment as the root cause, with stagnation of deficient qi and internal wind disturbing the collaterals as the key pathological mechanism,” breaking the traditional limitations in AF diagnosis and treatment thinking. Based on this innovative theory, the team established the fundamental treatment principle of “unblocking and tonifying collateral deficiency, extinguishing wind and calming palpitations,” selecting 14 authentic medicinal herbs scientifically combined to develop the hospital’s distinctive in-house preparation, Tongbu Fangchan Granules.

This formula overcomes the limitations of traditional antiarrhythmic drugs that target a single site. Animal experiments have shown that it can achieve multi-target, multi-pathway systemic intervention through three core mechanisms: myocardial electrical signal remodeling, cardiac structural remodeling, and autonomic nervous system regulation. It can both delay disease progression and comprehensively cover the full-course management needs of AF—including paroxysmal AF, persistent AF, and post-radiofrequency ablation recurrence prevention. For AF patients at different disease stages and treatment phases, it effectively improves core symptoms such as palpitations, shortness of breath, fatigue, and insomnia with vivid dreams. This provides a novel integrated Chinese-Western treatment solution for AF, filling the current clinical drug gap in comprehensive full-course AF management.

Furthermore, a clinical controlled study involving 72 patients with paroxysmal AF showed that, when combined with standardized Western medical treatment for three months, the formula reduced AF recurrence rates by 50% compared to Western medicine alone, decreased the number of episodes by 65% compared to pre-treatment, and extended the average time to recurrence by approximately 45 days, significantly reducing the frequency and duration of AF episodes.

The establishment of the Hebei Provincial Cardiovascular Specialty TCM Advantage Alliance has laid a high-quality collaborative platform for the integrated Chinese-Western diagnosis and treatment system of cardiovascular diseases throughout the province.

As the leading unit of the alliance, Hebei Yiling Hospital will take this opportunity to collaborate with member units to share innovative TCM diagnostic and treatment achievements and quality resources for cardiovascular diseases. Through academic exchanges, technology dissemination, talent training, and two-way referrals, the hospital will continuously improve the standardised diagnosis and treatment level of cardiovascular diseases across the province. This will enable more grassroots patients to enjoy high-quality, efficient integrated Chinese-Western medical services close to home, contributing sustained TCM strength to the construction of a Healthy Hebei and Healthy China.

Related reading